pCure Labs
LABS

Search product or substance info

Fluoxetine

Antidepressive Agents, Second-Generation
CATEGORIES

Antidepressive Agents, Second-Generation, Serotonin Uptake Inhibitors, Serotonin Agents


ALIASES

Adofen, Afeksin, Andepin, Bioxetin, Dagrilan, Deprex, Deprexetin, Exostrept, Felicium , Flonital, Floxet, Fluctine , Fluoxetine 1A Pharma , Fluoxetine 2care4, Fluoxetine AB, Fluoxetine AL, Fluoxetine AbZ, Fluoxetine Accord, Fluoxetine Actavis, Fluoxetine Almus, Fluoxetine Alter, Fluoxetine Amdipharm, Fluoxetine Apotex, Fluoxetine Arcana, Fluoxetine Aristo, Fluoxetine Arrow, Fluoxetine Aurobindo, Fluoxetine Aurovitas, Fluoxetine Azevedos, Fluoxetine BModesto, Fluoxetine Basi, Fluoxetine Benel, Fluoxetine Beta, Fluoxetine Biogaran, Fluoxetine Biomo, Fluoxetine Bluepharma, Fluoxetine CF, Fluoxetine Ciclum, Fluoxetine Cinfa, Fluoxetine Cristers, Fluoxetine Davur, Fluoxetine Dermogen, Fluoxetine Doc Generici, Fluoxetine Dura, Fluoxetine EGIS, Fluoxetine Ebb, Fluoxetine EuroGenerics, Fluoxetine Farmoz, Fluoxetine Fidia, Fluoxetine G.L., Fluoxetine GP, Fluoxetine Genericon, Fluoxetine Generics, Fluoxetine Generis, Fluoxetine Generis Phar, Fluoxetine Germed, Fluoxetine Hexal, Fluoxetine Jaba, Fluoxetine Kern Pharma, Fluoxetine Labesfal, Fluoxetine Lannacher, Fluoxetine Mabo, Fluoxetine Mylan, Fluoxetine Neuraxpharm, Fluoxetine Nodepe, Fluoxetine Normon, Fluoxetine Orifarm, Fluoxetine Orion, Fluoxetine Pharmakern, Fluoxetine Pharmex, Fluoxetine Polpharma, Fluoxetine Qualigen, Fluoxetine Ranbaxy, Fluoxetine Ratiopharm, Fluoxetine STADA, Fluoxetine Salipax, Fluoxetine Sandoz, Fluoxetine Tarbis, Fluoxetine Teva, Fluoxetine ToLife, Fluoxetine Tuneluz, Fluoxetine Uniche, Fluoxetine Vir, Fluoxetine Vitabalans, Fluoxetine Vitama, Fluoxetine Williams & Halls, Fluoxetine Wynn, Fluoxetine Zentiva, Fluoxetine Zydus, Fluoxetine-CT, Fluoxetine-RPh, Fluoxgamma, Fluoxone, Fluoxone Divule , Fluoxtab, Flustad, Fluval, Flux, Flux Hexal, Fluxemed, Fluxet, Fluxil, FluxoMed , Fluzac, Fluzak, Fodiss, Fokeston, Fontex, Gerozac, Ladose, Magrilan, Meropan, Mutan, Oxexin, Plazeron, Portal , Positivum, Prozac, Prozamel, Prozit, Psipax, Reconcile, Reneuron, Sartuzin, Selectus, Seromex, Seronil, Sofelin, Stephadilat, Stressless, Zinovat


SUBSTANCES

fluoxetine, fluoxetine hydrochloride


ENVIRONMENTAL CONCERN: HIGH
Fluoxetine hydrochloride is the first agent of the class of antidepressants known as selective serotonin-reuptake inhibitors (SSRIs). Fluoxetine is a racemic mixture of the R- and S- enantiomers and are of equivalent pharmacologic activity. Despite distinct structural differences between compounds in this class, SSRIs possess similar pharmacological activity. As with other antidepressant agents, several weeks of therapy may be required before a clinical effect is seen. SSRIs are potent inhibitors of neuronal serotonin reuptake. They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize α- or β-adrenergic, dopamine D2 or histamine H1 receptors. During acute use, SSRIs block serotonin reuptake and increase serotonin stimulation of somatodendritic 5-HT1A and terminal autoreceptors. Chronic use leads to desensitization of somatodendritic 5-HT1A and terminal autoreceptors. The overall clinical effect of increased mood and decreased anxiety is thought to be due to adaptive changes in neuronal function that leads to enhanced serotonergic neurotransmission. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction and headache. Side effects generally occur within the first two weeks of therapy and are usually less severe and frequent than those observed with tricyclic antidepressants. Fluoxetine may be used to treat major depressive disorder (MDD), moderate to severe bulimia nervosa, obsessive-compulsive disorder (OCD), premenstrual dysphoric disorder (PMDD), panic disorder with or without agoraphobia, and in combination with olanzapine for treatment-resistant or bipolar I depression. Fluoxetine is the most anorexic and stimulating SSRI.

Read More

IN SCOPE
HIGH

REFERENCES

  1. Metcalfe, C., K. Tindale, H. Li, A. Rodayan and V. Yargeau (2010). "Illicit drugs in Canadian municipal wastewater and estimates of community drug use." Environ Pollut 158, 3179-3185.
  2. Hedgespeth, M. L., Y. Sapozhnikova, P. Pennington, A. Clum, A. Fairey and E. Wirth (2012). "Pharmaceuticals and personal care products (PPCPs) in treated wastewater discharges into Charleston Harbor, South Carolina." Sci Total Environ 437, 1-9.
  3. Verlicchi, P., M. Al Aukidy, A. Galletti, M. Petrovic and D. Barceló (2012). "Hospital effluent: Investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment." Sci Total Environ 430, 109-118.
  4. Zorita, S., L. Mårtensson and L. Mathiasson (2009). "Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden." Sci Total Environ 407, 2760-2770.
  5. Sehonova, P., Svobodova, Z., Dolezelova, P., Vosmerova, P., Faggio, C., (2018). “Effects of waterborne antidepressants on non-target animals living in the aquatic environment: A review” Science of The Sci Total Enviro 631–632, 789-794.
  6. Dzieweczynski, T. L., Kane, J. L., Campbell, B. A., Lavin, E. L, (2016). “Fluoxetine exposure impacts boldness in female Siamese fighting fish, Betta splendens”, Ecotoxicology 25: 69
  7. Ford, T. A., Fong, P. P., (2016). “The effects of antidepressants appear to be rapid and at environmentally relevant concentrations”, Environ Toxicol Chem 35, 794-798
  8. Luna, T. O., Plautz, S. C. & Salice, C. J. (2015), “Chronic Effects of 17α-Ethinylestradiol, Fluoxetine, and the Mixture on Individual and Population-Level End Points in Daphnia magna”, Arch Environ Contam Toxicol 68: 603.
  9. Goodpoint. Prioritering av läkemedel med miljörisk inom SLL. Stockholm: Goodpoint; 2016. Rapport LS 2016–0634.
  10. IVL Swedish Environmental Research Institute Ltd. Fick J, Lindberg RH, Kaj L, Brorström-Lundén E. Results from the Swedish National Screening Programme 2010. Subreport 3. Pharmaceuticals.
  11. IVL Swedish Environmental Research Institute Ltd Fick J, Lindberg RH, Fång J, Magnér J, Kaj L, Brorström-Lundén E. Screening 2014. Analysis of pharmaceuticals and hormones in samples from WWTPs and receiving waters. Rapport C 135.
  12. Gaworecki KM, Klaine SJ. Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. Aquat Toxicol. 2008;88:207-13.
  13. Fick J, Lindberg RH, Tysklind M, Larsson DG. Predicted critical environmental concentrations for 500 pharmaceuticals. Regul Toxicol Pharmacol. 2010;58:516-23.
  14. SLL. Sammanställning av läkemedelsprovtagningar - Bearbetning av regional försäljningsstatistik av läkemedel samt datamaterial från Stockholms läns landstings mätprogram för läkemedelssubstanser i vattenmiljö, 2012–2016.
  15. Stockholms läns landsting. Förteckning över miljöbelastande läkemedel med åtgärdsförslag framtagen inom ramen för SLL:s miljöprogram 2017–2021.
  16. Goodpoint. Jämförande bedömning av miljörisk vid användning av citalopram, escitalopram, sertralin, fluoxetin, venlafaxin, paroxetin och klomipramin. Stockholm: Goodpoint; 2018.
  17. European Medical Agency - National registers of authorised medicines
  18. pCure Product Definition
  19. pCure Standard Dissolving Test

SOURCES

  1. Drugbank, The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug data with comprehensive drug target information.
  2. PubChem, PubChem is the world's largest collection of freely accessible chemical information. Search chemicals by name, molecular formula, structure, and other identifiers
  3. ECHA, The European Chemicals Agency (ECHA) is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.
  4. EMA, The mission of the European Medicines Agency (EMA) is to foster scientific excellence in the evaluation and supervision of medicines, for the benefit of public and animal health in the European Union (EU).
  5. EU watch-list, Commission Implementing Decision (EU) 2018/840 of 5 June 2018 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament.
  6. Umweltbundesamt, Since its founding in 1974, the German Environment Agency (Umweltbundesamt – UBA) has been Germany’s main environmental protection agency.
  7. Naturvårdsverket, A public agency in Sweden that is responsible for environmental issues. The Agency carries out assignments on behalf of the Swedish Government relating to the environment in Sweden, the EU and internationally
  8. Läkemedelsverket, The Swedish Medical Products Agency (MPA) is the Swedish national authority responsible for regulation and surveillance of the development, manufacturing and marketing of drugs and other medicinal products.
  9. FASS, The Swedish environmental classification of pharmaceuticals at www.fass.se has now been running since October 2005. Since then a large amount of environmental information of pharmaceuticals has been published.
  10. Janusinfo, Janusinfo is providing drug information to support healthcare professionals in their everyday work. The website is the electronic means of communication of the Drug Therapeutic Committee and the Health and Medical Care Administration of the Stockholm County Council, Sweden.